Advanced Neuroendocrine Carcinoma
4 clinical trials · Condition
◉ Watch Advanced Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma (NCT07520357) | Beijing GoBroad Hospital | 2026-04-30 |
| A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma (NCT06157827) | Nanjing Leads Biolabs Co.,Ltd | 2023-12-08 |
| At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer (NCT05969860) | Mayo Clinic | 2023-08-23 |
| A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma (NCT05015621) | Hutchison Medipharma Limited | 2021-09-18 |
Track Advanced Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.